Table 1.
Adverse Effect | Vaccine Type | Relative Risk | 95% CI |
---|---|---|---|
Overall adverse effects at the injection site [15] | Bivalent and quadrivalent | 1.18 | 1.16 to 1.20 |
Overall systemic events [15] | Bivalent and quadrivalent |
1.02 | 0.98 to 1.07 |
Serious adverse event [15] | Bivalent And quadrivalent |
1.01 | 0.95 to 1.07 |
Autoimmune-related conditions [25] | Bivalent | 0.98 | 0.80 to 1.21 |
Thromboembolic event [26] | Quadrivalent | 0.7 | 0.3 to 1.4 |
Chronic fatigue syndrome [27] | Quadrivalent | 0.94 | 0.78 to 1.14 |
Multiple sclerosis [28] | Quadrivalent | 0.3 | 0.1 to 0.9 |
Connective disorders [28] | Quadrivalent | 0.8 | 0.3 to 2.4 |
Type 1 diabetes [28] | Quadrivalent | 1.2 | 0.4 to 3.6 |
Guillain–Barré syndrome (GBS) [29] | Bivalent and quadrivalent | 3.78 | 1.79 to 7.98 |
Bivalent | 8.08 | 1.69 to 38.61 | |
Quadrivalent | 3.78 | 1.70 to 8.41 | |
Thyroiditis [30] | Bivalent | 3.75 | 1.25 to 11.31 |
Inflammatory bowel disease [29] | Bivalent and quadrivalent | 1.14 | 0.97 to 1.35 |
Bivalent [31] | 1.11 | 0.75 to 1.66 |